2026 annual financial data
Vistagen Therapeutics 2026 Operating margin
Vistagen Therapeutics 2026 operating margin with verified reported values.
Direct answer
Operating margin was -5,683.69%.
Operating income was -72,126,000 USD and net income was -69,685,000 USD.
Operating cash flow was -66,436,000 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,269,000 USD
- Operating income
- -72,126,000 USD
- Net income
- -69,685,000 USD
- Operating cash flow
- -66,436,000 USD